SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Delek Group Ltd. (DELKY) trades at a trailing P/E of 2.1. Trailing earnings yield is 46.73%. PEG 0.02 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (56/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 46.73% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $28.33 (-19.1% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 63/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
56/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DELKY
Valuation Multiples
P/E (TTM)2.1
Forward P/EN/A
PEG Ratio0.02
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.17
EV/EBITDA0.0
Per Share Data
EPS (TTM)$16.36
Book Value / Share$0.00
Revenue / Share$29.99
FCF / Share$0.00
Yields & Fair Value
Earnings Yield46.73%
Dividend Yield0.00%
Analyst Target$28.33 (-19.1%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$5.53 |
$5.78B |
$625M |
10.8% |
| 2017 |
$10.37 |
$6.84B |
$1.22B |
17.8% |
| 2018 |
$4.43 |
$8.13B |
$517M |
6.4% |
| 2019 |
$3.46 |
$8.8B |
$402M |
4.6% |
| 2020 |
$-9.62 |
$6.67B |
$-1.6B |
-23.9% |
| 2021 |
$7.83 |
$7.97B |
$1.43B |
18% |
| 2022 |
$22.37 |
$12B |
$3.98B |
33.2% |
| 2023 |
$8.73 |
$12.33B |
$1.59B |
12.9% |
| 2024 |
$7.60 |
$11.96B |
$1.4B |
11.7% |
| 2025 |
$16.36 |
$5.49B |
$2.99B |
54.5% |
